Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

When should dementia patients stop driving? A new guidance for clinicians

New guidance on when people living with dementia should stop driving has been published to support doctors and other health care professionals.

13 Dec 2018

Antibiotic-resistant bacteria could soon be targeted with Alzheimer's drug

Dangerous antibiotic-resistant bacteria could soon be targeted with a drug initially developed to treat Alzheimer's disease.

12 Dec 2018

Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages

Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time - a form of personalized medicine for neurodegenerative diseases.

11 Dec 2018

Study finds 117% increase in number of dementia sufferers in 26 years

An international group of collaborating scientists that includes HSE Professor Vasily Vlasov has analyzed data from 195 countries on the spread of Alzheimer's disease and other dementia between 1990 and 2016.

11 Dec 2018

Sacrificial immune cells alert body to infection

Scientists have discovered a new mechanism by which immune cells burst to alert the body to infection with Yersinia pestis.

11 Dec 2018

Researchers identify potential diagnostic tool for Alzheimer’s disease

Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive “tracer” molecules that bind to and “light up” tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer’s disease and other related dementias.

11 Dec 2018

Researchers to study effects of electroconvulsive therapy on Alzheimer’s patients with aggression

Researchers at McLean Hospital will lead a five-year study to investigate the use of electroconvulsive therapy to treat severe agitation and aggression in people with Alzheimer's disease.

11 Dec 2018

High-intensity interval exercise could help combat cognitive dysfunction in obese people

It's fast-paced, takes less time to do, and burns a lot of calories. High-intensity interval exercise is widely recognized as the most time-efficient and effective way to exercise.

10 Dec 2018

Episodic memory tests help in predicting brain atrophy and Alzheimer’s disease

Use of two episodic memory tests help in predicting brain atrophy and Alzheimer’s disease, as indicated by a study carried out at the University of Helsinki and the University of California. Researchers suggest that comprehensive use of memory tests could improve the diagnosis of mild cognitive impairment due to Alzheimer’s disease.

10 Dec 2018

Novel therapeutic targets based on biology of aging show promise for Alzheimer's disease

A scientific strategy that explores therapeutic targets based on the biology of aging is gaining ground as an effective approach to prevent and treat Alzheimer's disease, according to research published in the December 7, 2018 online issue of Neurology.

10 Dec 2018

Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases

Ivan Marazzi, PhD, Assistant Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, was awarded $2.5 million in funding by the Chan Zuckerberg Initiative to further the understanding of the underlying causes of neurodegenerative disorders such as Lou Gehrig's, Alzheimer's, and Parkinson's diseases. The

7 Dec 2018

Researchers are developing blood test to diagnose or predict Alzheimer's disease

Today, the only way to definitively diagnose Alzheimer's disease in life is through brain scans and tests of cerebrospinal fluid that must be collected via lumbar puncture. Though cumbersome and expensive, such tests provide the most accurate diagnoses for patients.

6 Dec 2018

Hazelnuts improve micronutrient levels in older adults

Older adults who added hazelnuts to their diet for a few months significantly improved their levels of two key micronutrients, new research at Oregon State University indicates.

6 Dec 2018

CWRU researcher secures $14.6 million funding for genetic study into Alzheimer's disease

Alzheimer's disease symptoms, such as memory loss or cognitive decline, can present in different ways among people with diverse ethnic backgrounds. Researchers know that a complex mix of social, behavioral, and genetic variables can impact the onset and progression of this disease.

6 Dec 2018

CZI announces over $51 million funding to fight neurodegenerative diseases

Today, the Chan Zuckerberg Initiative announced $64.25 million in funding and its selection of 17 early career investigators and nine collaborative science teams to launch the CZI Neurodegeneration Challenge Network

5 Dec 2018

Researchers create new approach to classify patients with Alzheimer's disease

Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

5 Dec 2018

Customizing Genetically Engineered Models for Specific Research Applications

In this interview conducted at SfN 2018, Philip Dubé from Taconic Biosciences, goes into detail about genetically engineered models and their importance in understanding neurodegenerative diseases.

From Taconic Biosciences, Inc. 4 Dec 2018

Governments across Europe respond in very different ways to lung cancer

The World Health Organization estimates 387,913 Europeans will die of lung cancer in 2018. The preliminary findings from a new study by the Economist Intelligence Unit comparing 13 countries show that governments across Europe are responding in very different ways to the disease.

4 Dec 2018

Latest advances in AI for aging and longevity research

Insilico Medicine, one of the leaders in artificial intelligence for drug discovery, biomarker development, digital medicine, and aging research announced today the publication of its recent paper titled "Artificial Intelligence for Aging and Longevity Research: Recent Advances and Perspectives" in Ageing Research Reviews, one of the highest-impact journals in the field.

3 Dec 2018

Researchers uncover genes that lead to excessive tau in dementia

Researchers have identified two major groups of genes involved in the mutations that lead to excess production of tau, a protein involved in dementia.

3 Dec 2018

Alzheimer's Disease News and Research

Further Reading

When should dementia patients stop driving? A new guidance for clinicians

Antibiotic-resistant bacteria could soon be targeted with Alzheimer's drug

Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages

Study finds 117% increase in number of dementia sufferers in 26 years

Sacrificial immune cells alert body to infection

Researchers identify potential diagnostic tool for Alzheimer’s disease

Researchers to study effects of electroconvulsive therapy on Alzheimer’s patients with aggression

High-intensity interval exercise could help combat cognitive dysfunction in obese people

Episodic memory tests help in predicting brain atrophy and Alzheimer’s disease

Novel therapeutic targets based on biology of aging show promise for Alzheimer's disease

Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases

Researchers are developing blood test to diagnose or predict Alzheimer's disease

Hazelnuts improve micronutrient levels in older adults

CWRU researcher secures $14.6 million funding for genetic study into Alzheimer's disease

CZI announces over $51 million funding to fight neurodegenerative diseases

Researchers create new approach to classify patients with Alzheimer's disease

Customizing Genetically Engineered Models for Specific Research Applications

Governments across Europe respond in very different ways to lung cancer

Latest advances in AI for aging and longevity research

Researchers uncover genes that lead to excessive tau in dementia

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News